,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,357,2,1,,11110922,305,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
1,410,1,5,,11110922,305,Inactive,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
2,411,2,1,,11110922,305,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
3,444,1,1,,11110922,305,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
4,445,3,1,,11110922,305,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
5,446,1,1,,11110922,305,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
6,447,1,1,,11110922,305,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
7,448,1,2,,11110922,305,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
8,450,1,2,,11110922,305,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
9,451,1,2,,11110922,305,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
10,526,1,1,,11110922,305,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
11,530,1,1,,11110922,305,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
12,584,1,3,,11110922,305,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
13,585,1,4,,11110922,305,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
14,587,1,5,,11110922,305,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
15,588,1,4,,11110922,305,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
16,589,1,3,,11110922,305,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
17,590,1,3,,11110922,305,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
18,591,1,4,,11110922,305,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
19,592,1,6,,11110922,305,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
20,593,1,4,,11110922,305,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
21,594,1,4,,11110922,305,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
22,595,1,3,,11110922,305,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
23,596,1,2,,11110922,305,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
24,597,1,3,,11110922,305,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
25,603,1,2,,11110922,305,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
26,605,1,2,,11110922,305,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
27,607,1,3,,11110922,305,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
28,662,1,1,,11110922,305,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
29,875,1,2,,11110922,305,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
30,879,1,2,,11110922,305,Inactive,3290016.0,6002.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
31,879,1,2,,11110922,305,Inactive,33946324.0,2770.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
32,881,2,2,,11110922,305,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
33,883,1,3,,11110922,305,Inactive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
34,884,1,2,,11110922,305,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
35,885,1,2,,11110922,305,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
36,886,1,2,,11110922,305,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
37,886,1,2,,11110922,305,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
38,887,1,2,,11110922,305,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
39,889,1,3,,11110922,305,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
40,891,1,2,,11110922,305,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
41,892,1,2,,11110922,305,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
42,893,1,2,,11110922,305,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
43,893,1,2,,11110922,305,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
44,895,1,2,,11110922,305,Inconclusive,21620132.0,4790.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway,Confirmatory,,
45,899,1,2,,11110922,305,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
46,900,1,3,,11110922,305,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
47,901,1,2,,11110922,305,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
48,902,1,2,,11110922,305,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
49,912,1,2,,11110922,305,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
50,914,1,3,,11110922,305,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
51,915,1,3,,11110922,305,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
52,917,1,3,,11110922,305,Inactive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
53,918,1,3,,11110922,305,Inconclusive,120660324.0,7066.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
54,923,1,2,,11110922,305,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
55,924,1,2,,11110922,305,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
56,925,1,2,,11110922,305,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
57,926,1,2,,11110922,305,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
58,927,1,3,,11110922,305,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
59,928,1,2,,11110922,305,Inconclusive,21620132.0,4790.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway,Confirmatory,,
60,938,1,2,,11110922,305,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
61,943,1,2,,11110922,305,Inconclusive,18249941.0,25229.0,17.7828,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response,Confirmatory,,
62,944,1,2,,11110922,305,Inactive,18249941.0,25229.0,,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response,Confirmatory,,
63,945,1,4,,11110922,305,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
64,954,1,2,,11110922,305,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle Pyruvate Kinase,Confirmatory,,
65,957,1,2,,11110922,305,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 4.5,Confirmatory,,
66,958,1,2,,11110922,305,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase,Confirmatory,,
67,959,1,4,,11110922,305,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
68,992,1,3,,11110922,305,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Human alpha-Galactosidase at pH 4.5,Confirmatory,,
69,995,1,2,,11110922,305,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
70,997,1,2,,11110922,305,Inactive,52076901.0,4341833.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Rice alpha-Glucosidase at pH 5.0,Confirmatory,,
71,998,1,2,,11110922,305,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 5.9,Confirmatory,,
72,1452,1,1,,11110922,305,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
73,1471,2,1,,11110922,305,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
74,1811,3,2,,46392765,305,Active,38492607.0,,,,Experimentally measured binding affinity data derived from PDB,Other,,
75,1811,3,2,,53812665,305,Active,112491230.0,,,,Experimentally measured binding affinity data derived from PDB,Other,16837465.0,
76,1851,1,2,,11110922,305,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
77,1851,1,2,1.0,11110922,305,Inactive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
78,1851,1,2,2.0,11110922,305,Inactive,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
79,1851,1,2,3.0,11110922,305,Inactive,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
80,1851,1,2,4.0,11110922,305,Inactive,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
81,1851,1,2,5.0,11110922,305,Inactive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
82,2660,1,1,,90340588,305,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
83,2666,1,1,,90340588,305,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
84,2667,1,1,,90340588,305,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
85,2668,1,1,,90340588,305,Inactive,4826730.0,2475.0,,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
86,32720,7,2,,103240245,305,Unspecified,,,3013.01,IC50,Inhibition acetylcholinesterase (AChE) enzyme.,Confirmatory,9435905.0,
87,51964,3,7,,103240245,305,Unspecified,,,,,Rate of acetylation of 13.0+/-1.1 umol compound by 1 g of choline acetyltransferase (ChAc) by incubating for 10 minutes at 37 degrees Centigrade,Other,6737417.0,
88,52113,6,4,,103240245,305,Unspecified,,,290.0,Km,Apparent Michaelis-Menten Constant (KM) for the acetylation of compound was calculated from Linewear-Burke plots by incubating for 10 minutes at 37 degrees Centigrade,Confirmatory,6737417.0,
89,52115,3,7,,103240245,305,Unspecified,,,,,Apparent Michaelis-Menten Constant (Vmax) for the acetylation of compound,Other,6737417.0,
90,52130,9,2,,103240245,305,Active,,,1.6,IC50,In vitro ability to inhibit the transport of [3H]choline in to high affinity choline transport system HAChT,Confirmatory,3950917.0,
91,52133,9,1,,103240245,305,Active,,,42.0,Ki,Inhibition of [3H]-choline brain uptake was determined by in situ brain perfusion studies in male rats,Confirmatory,15149650.0,
92,68051,6,2,,103240245,305,Unspecified,,,,,Minimum concentration required to inhibit Enterococcus faecalis ATCC 29212,Other,12954069.0,
93,68053,5,1,,103240245,305,Unspecified,,,,,Minimum concentration required to inhibit Enterococcus faecalis ATCC 29212,Other,12954069.0,
94,70621,6,2,,103240245,305,Unspecified,,,,,Minimum concentration required to inhibit Escherichia coli ATCC 25922,Other,12954069.0,
95,70623,5,1,,103240245,305,Unspecified,,,,,Minimum concentration required to inhibit Escherichia coli ATCC 25922,Other,12954069.0,
96,145685,7,4,,103240245,305,Active,113061.0,25101.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
97,145685,7,4,,103240245,305,Active,113066.0,25102.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
98,145685,7,4,,103240245,305,Active,113108.0,171131.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
99,145685,7,4,,103240245,305,Active,113111.0,25103.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
100,145685,7,4,,103240245,305,Active,1168297.0,81721.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
101,145685,7,4,,103240245,305,Active,2851491.0,170945.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
102,145685,7,4,,103240245,305,Active,6226548.0,54239.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
103,145685,7,4,,103240245,305,Active,8469182.0,25590.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
104,145685,7,4,,103240245,305,Active,68051992.0,64574.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
105,145685,7,4,,103240245,305,Active,68067466.0,65024.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
106,145685,7,4,,103240245,305,Active,146345356.0,25302.0,42.0,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,Confirmatory,15050613.0,
107,145983,8,5,,103240245,305,Active,2851491.0,170945.0,18.0,Ki,Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
108,145983,8,5,,103240245,305,Active,6226548.0,54239.0,18.0,Ki,Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
109,146006,8,5,,103240245,305,Active,113061.0,25101.0,37.0,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
110,146006,8,5,,103240245,305,Active,6226548.0,54239.0,37.0,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
111,146162,8,5,,103240245,305,Active,113061.0,25101.0,48.0,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
112,146162,8,5,,103240245,305,Active,113111.0,25103.0,48.0,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
113,146486,8,5,,103240245,305,Active,6226548.0,54239.0,37.0,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
114,146486,8,5,,103240245,305,Active,8469182.0,25590.0,37.0,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
115,146772,8,5,,103240245,305,Active,113111.0,25103.0,34.0,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
116,146772,8,5,,103240245,305,Active,8469182.0,25590.0,34.0,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
117,163955,6,2,,103240245,305,Unspecified,,,,,Minimum concentration required to inhibit Pseudomonas aeruginosa ATCC 27853,Other,12954069.0,
118,163958,5,1,,103240245,305,Unspecified,,,,,Minimum concentration required to inhibit Pseudomonas aeruginosa ATCC 27853,Other,12954069.0,
119,207553,6,2,,103240245,305,Unspecified,,,,,Minimum concentration required to inhibit Staphylococcus aureus ATCC 25923,Other,12954069.0,
120,207555,5,1,,103240245,305,Unspecified,,,,,Minimum concentration required to inhibit Staphylococcus aureus ATCC 25923,Other,12954069.0,
121,225720,6,2,,103240245,305,Active,,,21.0,Ki,Binding affinity towards rat alpha2-beta4 nACh receptor expressed in HEK293 cells using [3H]EB as radioligand,Confirmatory,15050613.0,
122,231911,3,3,,103240245,305,Unspecified,,,,,Ratio between the binding affinities towards rat alpha2-beta4 and alpha2-beta2 nACh receptor using [3H]-EB as radioligand,Other,15050613.0,
123,231912,3,4,,103240245,305,Unspecified,,,,,Ratio between the binding affinities towards rat alpha3-beta4 and alpha3-beta2 nACh receptor using [3H]EB as radioligand,Other,15050613.0,
124,231914,3,4,,103240245,305,Unspecified,,,,,Ratio between the binding affinities towards rat alpha3-beta4 and forebrain nACh receptor using [3H]EB as radioligand,Other,15050613.0,
125,231915,3,4,,103240245,305,Unspecified,,,,,Ratio between the binding affinities towards rat alpha4-beta4 and alpha4-beta2 nACh receptor using [3H]EB as radioligand,Other,15050613.0,
126,242872,9,1,,103240245,305,Unspecified,146345356.0,25302.0,,,Maximal response against Nicotinic acetylcholine receptor alpha 7,Other,16033252.0,
127,344669,6,2,,103240245,305,Active,,,41.0,Ki,Binding affinity to blood-brain barrier choline transporter in rat brain assessed as inhibition of [3H]choline uptake,Confirmatory,18793853.0,
128,386623,4,8,,103240245,305,Unspecified,313104181.0,6580.0,,,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells at 100 uM by confocal microscopy,Other,18788725.0,
129,463106,1,2,,90340588,305,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
130,483710,5,2,,103240245,305,Active,,,41.0,Ki,Binding affinity to blood-brain barrier choline transporter in rat brain assessed as inhibition of [3H]choline uptake,Confirmatory,20462759.0,
131,485295,1,2,,90340588,305,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
132,485297,1,1,,90340588,305,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
133,485298,1,1,,90340588,305,Inactive,,,5.8048,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
134,485313,1,2,,90340588,305,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
135,485342,1,2,,90340588,305,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
136,485345,1,2,,90340588,305,Inactive,,,,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
137,485366,1,2,,90340588,305,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
138,485368,1,2,,90340588,305,Inconclusive,72386991.0,3656265.0,0.1694,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
139,488772,1,1,,90340588,305,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
140,488773,1,2,,90340588,305,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
141,488816,1,1,,90340588,305,Inactive,4758356.0,2237.0,,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
142,488837,1,1,,90340588,305,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
143,488949,1,2,,90340588,305,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
144,488953,1,1,,90340588,305,Inactive,187960037.0,10951.0,,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
145,488978,1,1,,90340588,305,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
146,488981,1,1,,90340588,305,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
147,488982,1,1,,90340588,305,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
148,488983,1,1,,90340588,305,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
149,493106,1,1,,90340588,305,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
150,493107,1,1,,90340588,305,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
151,493153,1,1,,90340588,305,Inactive,,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
152,493153,1,1,,90340588,305,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
153,493164,1,2,,90340588,305,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
154,493164,1,2,,90340588,305,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
155,493164,1,2,,90340588,305,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
156,504327,1,1,,90340588,305,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
157,504332,1,1,,90340588,305,Inconclusive,168985070.0,,1.2589,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
158,504536,1,1,,90340588,305,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
159,504547,1,1,,90340588,305,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
160,504548,1,2,,90340588,305,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
161,504810,1,2,,90340588,305,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
162,504812,1,2,,90340588,305,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
163,504836,1,2,,90340588,305,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
164,504845,1,1,,90340588,305,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
165,504847,1,1,,90340588,305,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
166,504865,1,1,,90340588,305,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
167,540256,1,2,,90340588,305,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
168,540276,1,2,,11110922,305,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
169,540276,1,2,,50110963,305,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
170,540276,1,2,,90340588,305,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
171,588349,1,1,,90340588,305,Inactive,,,,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
172,588378,1,1,,90340588,305,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
173,588453,1,1,,90340588,305,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
174,588456,1,1,,90340588,305,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
175,588579,1,1,,90340588,305,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
176,588795,1,1,,90340588,305,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
177,602332,1,1,,90340588,305,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
178,624030,1,2,,90340588,305,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
179,624146,1,1,,90340588,305,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
180,624147,1,1,,90340588,305,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
181,624148,1,2,,90340588,305,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
182,624149,1,1,,90340588,305,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
183,624170,1,1,,90340588,305,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
184,624172,1,1,,90340588,305,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
185,624173,1,3,,90340588,305,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
186,624455,1,1,,90340588,305,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
187,678785,3,6,,103240245,305,Unspecified,81882176.0,20518.0,217.0,IC50,TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in Xenopus laevis oocytes,Confirmatory,12176030.0,
188,678794,3,6,,103240245,305,Unspecified,189046191.0,20517.0,55.0,IC50,TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 1 uM) in Xenopus laevis oocytes,Confirmatory,12176030.0,
189,678957,2,7,,103240245,305,Unspecified,313104182.0,6582.0,210.0,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,9260930.0,
190,678970,3,6,,103240245,305,Unspecified,81872789.0,29503.0,159.0,IC50,TP_TRANSPORTER: inhibition of TEA uptake (TEA: 100 uM) in Xenopus laevis oocytes,Confirmatory,10082798.0,
191,678993,2,7,,103240245,305,Unspecified,81872095.0,24904.0,370.0,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,10570053.0,
192,679159,2,7,,103240245,305,Unspecified,313104182.0,6582.0,190.0,Km,TP_TRANSPORTER: uptake (electrogenesis) in Xenopus laevis oocytes,Confirmatory,9260930.0,
193,679188,2,7,,103240245,305,Unspecified,81872095.0,24904.0,346.0,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,11553644.0,
194,679207,1,7,,103240245,305,Unspecified,81872095.0,24904.0,,,"TP_TRANSPORTER: inhibition of TEA uptake (TEA: 500 uM, Choline: 5000 uM) in OCT1A expressing Xenopus laevis oocytes",Other,9195965.0,
195,679314,2,7,,103240245,305,Unspecified,81872095.0,24904.0,1100.0,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,8955087.0,
196,679635,2,7,,103240245,305,Unspecified,81872789.0,29503.0,2000.0,Km,TP_TRANSPORTER: uptake (electrogenesis) in Xenopus laevis oocytes,Confirmatory,10889205.0,
197,679824,1,7,,103240245,305,Unspecified,81872095.0,24904.0,,,TP_TRANSPORTER: uptake in OCT1-expressing HEK293 cells,Other,10385678.0,
198,679825,2,7,,103240245,305,Unspecified,81872095.0,24904.0,240.0,Km,"TP_TRANSPORTER: uptake (electrogenesis,-50mV) in Xenopus laevis oocytes",Confirmatory,8955087.0,
199,679826,3,6,,103240245,305,Unspecified,81872095.0,24904.0,398.0,IC50,TP_TRANSPORTER: inhibition of TEA uptake (TEA: 100 uM) in Xenopus laevis oocytes,Confirmatory,10082798.0,
200,680370,2,7,,103240245,305,Unspecified,189046191.0,20517.0,,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,10216142.0,
201,680371,2,7,,103240245,305,Unspecified,189046191.0,20517.0,42.0,Km,TP_TRANSPORTER: uptake in Oct1-expressing BALB/3T3 cells,Confirmatory,11060354.0,
202,680376,1,7,,103240245,305,Unspecified,8928277.0,20520.0,,,TP_TRANSPORTER: inhibition of carnitine uptake by Choline at 500uM in Octn2-HEK cells,Other,11010964.0,
203,680408,1,8,,103240245,305,Unspecified,146345508.0,6583.0,,,"TP_TRANSPORTER: inhibition of TEA uptake (TEA: 60 uM, Choline: 5000 uM) in Xenopus laevis oocytes",Other,10215651.0,
204,680544,1,7,,103240245,305,Unspecified,8928277.0,20520.0,,,"TP_TRANSPORTER: inhibition of Carnitine uptake (Carnitine: 0.01 uM, Choline: 500 uM) in OCTN2-expressing HEK293 cells",Other,11160873.0,
205,681117,3,6,,103240245,305,Unspecified,313104181.0,6580.0,,IC50,TP_TRANSPORTER: inhibition of TEA uptake in OCT1-expressing HeLa cells,Confirmatory,12606755.0,
206,681345,3,6,,103240245,305,Unspecified,81872789.0,29503.0,1450.0,IC50,TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT2-expressing MDCK cells,Confirmatory,11758759.0,
207,681348,3,6,,103240245,305,Unspecified,81872095.0,24904.0,1452.0,IC50,TP_TRANSPORTER: inhibition of TEA uptake (TEA: 50 uM) in OCT1-expressing MDCK cells,Confirmatory,11758759.0,
208,681589,2,7,,103240245,305,Unspecified,81872789.0,29503.0,604.0,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,11502595.0,
209,681624,2,7,,103240245,305,Unspecified,81872789.0,29503.0,441.0,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,11553644.0,
210,681628,1,7,,103240245,305,Unspecified,81872789.0,29503.0,,,TP_TRANSPORTER: uptake in OCT2-expressing HEK-293 cells,Other,11502595.0,
211,681707,1,7,,103240245,305,Unspecified,8928242.0,29726.0,,,"TP_TRANSPORTER: inhibition of TEA uptake (TEA: 20 uM, Choline: 2500 uM) in OCTN2-expressing HRPE cells",Other,10454528.0,
212,681712,1,7,,103240245,305,Unspecified,8928242.0,29726.0,,,"TP_TRANSPORTER: inhibition of Carnitine uptake (Carnitine: 0.025 uM, Choline: 2000 uM) in OCTN2-expressing HRPE cells",Other,10454528.0,
213,681945,1,7,,103240245,305,Unspecified,313104181.0,6580.0,,,"TP_TRANSPORTER: inhibition of TEA uptake (TEA: 5 uM, Choline: 500 uM) in OCT1-expressing HeLa cells",Other,9655880.0,
214,681957,1,7,,103240245,305,Unspecified,313104181.0,6580.0,,,"TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 0.85 uM, Choline: 1000 uM) in Xenopus laevis oocytes",Other,9187257.0,
215,681960,2,7,,103240245,305,Unspecified,313104182.0,6582.0,102.0,Km,TP_TRANSPORTER: uptake in Xenopus laevis oocytes,Confirmatory,11553644.0,
216,681966,1,7,,103240245,305,Unspecified,313104182.0,6582.0,,,"TP_TRANSPORTER: inhibition of TEA uptake (TEA: 75 uM, Choline: 1000 uM) in Xenopus laevis oocytes",Other,11553644.0,
217,681998,1,7,,103240245,305,Unspecified,313104182.0,6582.0,,,"TP_TRANSPORTER: inhibition of TEA uptake (TEA: 5 uM, Choline: 1000 uM) in OCT2A-expressing HEK293 cells",Other,12089365.0,
218,682099,1,8,,103240245,305,Unspecified,189046191.0,20517.0,,,TP_TRANSPORTER: no change in tissue distribution in Oct1 -/- mouse,Other,11463829.0,
219,682231,1,7,,103240245,305,Unspecified,24212062.0,29504.0,,,"TP_TRANSPORTER: inhibition of Guanidine uptake (Guanidine: 35 uM, Choline: 5000 uM) in OCT3-expressing HeLa cells",Other,9632645.0,
220,682270,1,7,,103240245,305,Unspecified,8928257.0,6584.0,,,"TP_TRANSPORTER: inhibition of TEA uptake (TEA: 20 uM, Choline: 5000 uM) in OCTN2-expressing HeLa cells",Other,9618255.0,
221,682276,1,7,,103240245,305,Unspecified,8928257.0,6584.0,,,"TP_TRANSPORTER: inhibition of Carnitine uptake (Carnitine: 0.025 uM, Choline: 2000 uM) in OCTN2-expressing HRPE cells",Other,10454528.0,
222,977611,3,1,,46392765,305,Active,38492607.0,,3600.0,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,,
223,977611,3,1,,53812665,305,Active,112491230.0,,930.0,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,16837465.0,
224,977611,3,1,,170481258,305,Active,203282240.0,,2.3,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,18779321.0,
225,977611,3,1,,170483711,305,Active,332639773.0,,28.0,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,21366542.0,
226,977611,3,1,,170483933,305,Active,340708458.0,,30.5,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,21658392.0,
227,1159607,2,1,,312996562,305,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
228,1224863,1,1,,316919150,305,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
229,1259409,1,1,,363903797,305,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
230,1259416,1,2,,340085172,305,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
231,1259421,1,1,,340085172,305,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
232,1259423,1,2,,354818623,305,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
233,1259423,1,2,,354977349,305,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
234,1259423,1,2,,355015642,305,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
